Denali Therapeutics (DNLI) Return on Sales [ROS] (2018 - 2026)
Denali Therapeutics (DNLI) recorded Return on Sales [ROS] of -712.97% in Q3 2026, up 2909.15 percentage points from the prior quarter.
Powered by 
Analysis
Denali Therapeutics (DNLI) Return on Sales [ROS] (2018 - 2026) Analysis & Trends
On a TTM basis, Denali Therapeutics' Return on Sales [ROS] came in at -2488.14% as of Sep 30, 2026; for FY2023, it came in at -59.51%, up 254.65 percentage points from FY2022.
- Annual Return on Sales [ROS] has a five-year change of -23.61 percentage points (FY2018 to FY2023).
- Across earlier years, Return on Sales [ROS] came in at -314.16% in FY2022 (+293.62 pp), -607.78% in FY2021 (-626.46 pp), 18.69% in FY2020 (+817.79 pp) and -799.10% in FY2019 (-763.20 pp).
- The Q3 2026 figure is the highest quarterly Return on Sales [ROS] since Q1 2024.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 964.94 percentage points in Q4 2023, against a drop of 37996.01 percentage points in Q2 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Denali Therapeutics | 3.18 Bn | 98.89 Mn | 17.59 Mn | -712.97% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -712.97% |
| Jun 30, 2026 | -3,622.11% |
| Jun 30, 2024 | -37,938.04% |
| Mar 31, 2024 | -65.54% |
| Dec 31, 2023 | -59.51% |
| Sep 30, 2023 | -8,981.45% |
| Jun 30, 2023 | 57.96% |
| Mar 31, 2023 | -343.80% |
| Dec 31, 2022 | -1,024.45% |
| Sep 30, 2022 | -3,020.12% |
| Jun 30, 2022 | -117.03% |
| Mar 31, 2022 | -157.80% |
| Dec 31, 2021 | -616.28% |
| Sep 30, 2021 | -1,619.55% |
| Jun 30, 2021 | -269.48% |
| Mar 31, 2021 | -898.90% |
| Dec 31, 2020 | 77.04% |
| Sep 30, 2020 | -640.01% |
| Jun 30, 2020 | -1,048.01% |
| Mar 31, 2020 | -1,663.90% |
API Access
Denali Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=DNLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "DNLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=DNLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();